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Abstract
Fetal growth restriction (FGR) is a pregnancy condition in which fetal growth is suboptimal
for gestation, and this population is at increased risk for type 2 diabetes as adults. In humans,
maternal malnutrition and placental insufficiency are the most common causes of FGR, and
both result in fetal undernutrition. We hypothesized that maternal nutrient restriction
(MNR) in mice will cause FGR and alter glucose metabolism in adult offspring. Pregnant
CD-1 mice were subjected to MNR (70% of average ad libitum) or control (ad libitum) from
E6.5 to birth. Following birth, mice were fostered by mothers on ad libitum feeds. Weight,
blood glucose, glucose tolerance and tissue-specific insulin sensitivity were assessed in male
offspring. MNR resulted in reduced fetal sizes but caught up to controls by 3 days postnatal
age. As adults, glucose intolerance was detected in 19% of male MNR offspring. At 6 months,
liver size was reduced (P= 0.01), but pAkt-to-Akt ratios in response to insulin were increased
2.5-fold relative to controls (P= 0.004). These data suggest that MNR causes FGR and long-
term glucose intolerance in a population of male offspring similar to human populations. This
mouse model can be used to investigate the impacts of FGR on tissues of importance in
glucose metabolism.
Introduction
Fetal growth restriction (FGR) or intrauterine growth restriction (IUGR) is a pregnancy
condition in which the fetus fails to achieve optimal growth expected for gestational age
resulting in a small for gestational age (SGA) newborn with birth weight of <10th percentile.
The most common causes include maternal malnutrition in developing countries and pla-
cental insufficiency in developed countries.1 Irrespective of the cause, poor macro- and micro-
nutrient and substrate concentrations in the fetus are common pathophysiological findings.
Growth-restricted infants are at increased risk for morbidity and mortality in the perinatal
period,2 and for many chronic diseases, including cardiovascular diseases,3 metabolic dis-
orders such as type 2 diabetes and glucose intolerance,3 and obesity and abnormal lipid
metabolism.4
Associations between poor fetal growth and adult health and disease have led to the
concept of Developmental Origins of Health and Disease (DOHaD), which proposes that
environmental exposures such as nutrient restriction during development can result in
metabolic adaptations,5 which may enhance the survival of the fetus but increase their risk for
metabolic disorders as children and adults. The concept of a mismatched environment
underlying the association between fetal nutrient environment and predisposition to adult
diseases is defined in the ‘thrifty phenotype hypothesis.’5
FGR has been studied using maternal nutrient restriction (MNR) in animals such as rats6–8
and guinea pigs,9 or larger mammals like pigs,10,11 providing a short lifespan or similar
morphology and diet to humans, respectively. These models have a limited capacity for genetic
manipulation in offspring to identify genes and epigenetic changes moderating impacts of fetal
nutrition. Such limitations can be addressed by using MNR in mice.
Models of growth restriction in rodents with variation in the duration of nutrient
restriction provide insight on certain types of fetal undernutrition, either due to the onset of
placental insufficiency or food availability. For example, nutrient restriction before and
throughout pregnancy9,12 in rodents model mothers that experience extended nutritional defi-
cits, however, does not mimic fetal undernutrition due to placental insufficiency. Conversely,
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nutrient restriction beginning later in gestation may represent
placental insufficiency.6 Nutrient restriction just after implantation
in the mouse at E6.5 has not been studied and would be more
similar to early- to mid-gestation-onset placental insufficiency.
Evidence suggests that metabolic adaptations to fetal under-
nutrition are tissue-specific and serum peptides for obesity and
diabetes can aid in identification of impacted tissues. Incretin
hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-
dependent insulinotropic peptide (GIP), are released by the gut
upon ingestion of food and stimulate release of insulin.13,14
Pancreatic hormones, such as insulin and glucagon, regulate
tissue glucose uptake and energy utilization. In addition to hor-
mone release, c-peptide, the cleaved portion of proinsulin, can
indicate changes in insulin maturation.15 Leptin, resistin16 and
plasminogen activator inhibitor (PAI-1)17 are secreted primarily
from adipose tissue in mice. Leptin along with ghrelin, which is
released from the gut, regulate appetite.18,19 Changes in these
markers in addition to other metabolic tests can provide insight
into tissues with metabolic adaptations.
The objective of this study was to establish a moderate total
calorie nutrient restriction in mice to mimic human FGR popu-
lations and examine the long-term metabolic complications. We
hypothesized that a 30% reduction in maternal food consumption
by weight during early and late pregnancy would result in reduced
fetal and newborn weight and tissue-specific alterations in adult
glucose metabolism similar to humans.
Methods
Animals
The animal experiments were conducted as approved by the
Council on Animal Care at the University of Western Ontario. All
mice received free access to water in a standard 12 h light/dark
cycle. Eight-week-old virgin female CD-1 mice, obtained from
Charles River Laboratories (Montreal, PQ, Canada), were mated
and the presence of mucous plugs indicated E0.5. After mating
mice were housed individually. To avoid reduction in the number
of conceptuses of each litter, mated females received ad libitum
until after embryo implantation at about E5. At E6.5, the mice
were randomly assigned into two groups, the control group was
fed ad libitum and the MNR group was fed 70% average ad
libitum total calorie intake (both groups receiving #F0173, Bio-
Serv, Flemington, NJ, USA). At E18.5, 3 control and 3 MNR
pregnant females were euthanized by CO2 narcosis. No differ-
ences between the number of males and females were observed
between MNR and control litters (Supplementary Table 1). Litter
size ranged from 6 to 22 pups. To control for variations in litter
size, only litters with 11–15 pups were analyzed in fetal (control
litters= 3, MNR litters= 3) and long-term studies (control lit-
ters= 5, MNR litters= 10). Because many studies suggest that
male offspring are more sensitive to maternal undernutrition20–22
and that postreproductive changes complicate long-term studies
in females,23 only males were examined in this study. SRY
polymerase chain reaction (forward primer: TGGACTGGTGA-
CAARGCTA, reverse primer: TGGAAGTACAGGTGTGCACT
CT) was used in fetal studies to include males only (control:
n= 21, MNR: n= 15). Tissues were snap frozen in liquid nitrogen.
For postnatal studies, pups’ paws were tattooed at birth in
order to track weights for each pup with the Armis Microtatoo kit
(Braintree Scientific, Inc., Braintree, MA, USA). All litters were
cross-fostered to females that were fed ad libitum throughout
pregnancy and the litters were culled or fostered to 13 pups each.
Ad libitum standard chow (Teklad LM-485 Mouse/Rat Sterilizable
Diet, Mississauga, ON, Canada) was used for the remainder of the
study in both MNR and control offspring.
At weaning (P21), only male offspring were kept for further
study (control litters: n= 5, MNR litters: n= 10) and were housed
with 3–5 siblings per cage. Weight was measured once a month.
With the exception of littermates used for the intrahepatic portal
vein insulin challenge, offspring at 1 month (control: n= 8, MNR:
n= 16) and 6 months (control: n= 25, MNR: n= 36) were
euthanized with CO2 narcosis. Weight was measured, and serum
was collected through intracardiac puncture. Individual liver
lobes, perigonadal adipose tissue and quadriceps femoris were
collected, snap frozen in liquid nitrogen and stored at −80°C until
analysis. Animals used for the intrahepatic portal vein insulin
challenge (n= 8 per group) were euthanized at 7 months after
tissue collections.
Glucose tolerance and hepatic glucose production
Glucose tolerance was assessed in 36 MNR (10 litters) and 25
controls (5 litters, 3–8 pups/litter) one week before tissue coll-
ections at 6 months by intraperitoneal glucose tolerance testing
(IP-GTT). Briefly, fasted mice (4 h) (at 8:00 am) were injected
with glucose 2 g/kg body weight and blood glucose was measured
via tail vein every 30min for 2 h using a Freestyle Lite Glucometer
(Abbott, Alameda, CA, USA). Hepatic glucose output was mea-
sured with a pyruvate challenge test (5 pups per group, 1 pup/
litter). Pyruvate was injected (IP) into mice fasted for 4 h (at
8:00 am) at 2 g/kg body weight and blood glucose was measured
via tail vein every 30min for 2 h.
Random blood glucose
Once a month from 1 to 6 months, random blood glucose
(nonfasted) was measured. Blood samples were collected at 10:30
am via tail vein prick and measured using a Freestyle Lite
Glucometer.
Intrahepatic portal vein insulin challenge test
At 7 months old, mice were fasted for 4 h and anaesthetized with
isoflurane. Using a mid-line incision, intestines were moved to
expose the hepatic portal vein and 2U/kg of insulin (Humalin R,
Eli Lilly Canada Inc., Toronto, ON, Canada) (control and MNR
n= 5, 1 pup/litter) or saline (control and MNR n= 3, 1 pup/litter)
was injected. After 1min and 15 s, a piece of right medial liver
lobe, a quadriceps femoris muscle and perigonadal fat were frozen
in liquid nitrogen. Samples were stored in −80°C until western
blot analysis.24
Protein isolations
The experiment was conducted with 50mg of frozen liver and
muscle and 100mg of adipose tissue that were pulverized
(Medium Bessman Tissue Pulverizer, Spectrum Laboratories,
Rancho Dominguez, CA, USA) and then homogenized for 30 s
with the Brinkmann Homogenizer Polytron® 3000 in 1 × cell
lysis buffer (9803S, Cell Signaling Technology® Inc., Danvers,
MA, USA) and protease inhibitor cocktail 1, 2 and 3 (P1860,
P5726 and P0044, Sigma-Aldrich, St Louis, MO, USA). The
homogenate was then sonicated (F550 Sonic Dismemberator,
Fisher Scientific, Markham, ON, Canada) and rocked for 40min
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at 4°C. Samples were spun at 12,000 g for 10min at 4°C and the
supernatant was collected with care, not to collect the lipid layer,
and stored at −20°C until analysis. Protein quantification was
done with the Bio-Rad protein assay dye according to the manu-
facturer’s protocol using bovine serum albumin (BSA) standards
(Cat #500-0006, Bio-Rad Laboratories Inc., Des Plaines, IL, USA).
Western blotting
Protein samples were boiled in sodium dodecyl sulfate (SDS)
sample loading buffer with dithiothreitol at 75°C for 5min and
then incubated on ice for 5min. A 10 μg of protein was loaded
and run on a 10% SDS polyacrylamide gel. Proteins were trans-
ferred to a polyvinylidene difluoride membrane using the Trans-
Blot® Turbo™ Transfer System and Trans-Blot® Turbo™ RTA
Midi Transfer Kit (170-4273, Bio-Rad Laboratories Inc.) accord-
ing to the manufacturer’s protocol.
Once the transfer was completed, membranes were dipped in
methanol and blocked with 5% milk in TBST [tris buffered saline
(TBS) + 1% tween]. Blocking buffer was rinsed from the mem-
brane for 5min (3 × ) with TBST at room temperature (RT).
Primary antibody for pAkt (#4000, rabbit mAB, Cell Signaling
Technology® Inc.) was diluted 1: 1000 into 5% BSA in TBST and
incubated with blots shaking at overnight at 4°C. Membranes
were rinsed with TBST 3 × (5min) at RT and then incubated with
secondary rabbit IgG (#170-6515, Bio-Rad Laboratories Inc.)
diluted 1: 10 000 in 5% milk in TBST for 1 h at RT. After rinsing
the secondary antibody, ClarityTM Western ECL substrate (#170-
5061, Bio-Rad Laboratories Inc.) and a VersaDoc Imaging System
(Bio-Rad Laboratories Inc.) were used to capture an image of the
gel. Membranes were then rinsed and stripped with 0.5M NaOH,
rinsed in TBS (3 × 5min at RT) and reprobed with Akt (#9272,
Bio-Rad Laboratories Inc.), according to the protocol mentioned
earlier.
Quantification of blots was done using Imagelab software®
version 5.1 BETA (Bio-Rad Laboratories Inc.) and quantities were
compared using pAkt to total Akt ratios.
Serum peptide markers for obesity and diabetes
Blood samples collected by intracardiac puncture at 1 month
(control: n= 7, MNR: n= 18, 4 control and 10 MNR litters, 1–2
pups/litter) and 6 months (5 control and 10 MNR litters, 3–7
pups/litter, MNR: n= 52, control n= 30) in nonfasted mice (8:30–
9:30 am) were used in this multiplex assay. At the time of col-
lection, protease inhibitors, 10mM DPP-IV (EMD Millipore,
DPP4-010) and 1.3% aprotinin inhibitor (EMD Millipore,
616399), both in 0.9% sterile saline, were added to the blood
samples (10 ul/ml). Samples were allowed to clot for 45min and
spun at twice at 12,000 g for 10min to obtain serum. All serum
samples were stored at −80°C. Ghrelin, leptin, insulin, glucagon,
PAI-1, GLP, GIP and resistin were assayed on the Bio-Rad
Multiplex at Lawson’s Multiplex Facility, London, ON, using the
Bio-Plex Pro Mouse Diabetes Assay (171F7001M, Bio-Rad
Laboratories Inc.). Serum C-peptide was also quantified accord-
ing to the manufacturer’s protocol (Mouse C-Peptide ELISA,
80-CPTMA-E1, Alpco, Salem, NH).
Lipid quantification in serum and liver
An aliquot of nonfasted serum as described earlier was used for
cholesterol (Cholesterol Quantification Kit MAK043, Sigma-
Aldrich®, St Louis, MO, USA) and triglyceride quantification
(Triglyceride Quantification Assay Kit ab65336, Abcam®,
Cambridge, MA, USA). Liver cholesterol was also isolated from
nonfasted liver tissue and quantified according to the manu-
facturer’s protocol. Measurements were taken from 5 control and
10 MNR litters, 3–6 pups/litter.
Statistical analysis
Data are presented as mean± SEM. For glucose tolerance testing,
pyruvate challenge tests and random blood glucose measure-
ments, a repeated measure ANOVA and Bonferroni post-hoc
correction were used. For all other analyses, Mann–Whitney test
was used to compare means where samples sizes were >8, and an
unpaired t-test with ⩽ 8 samples. Means are considered sig-
nificantly different if P< 0.05. All statistics and graphs were
produced in Prism software (GraphPad®, version 5.2), or the R
console (version 3.3.2) with ggplot2® (version 2.2.1) and Sciplot®
(version 1.1–0) software packages.
Results
Maternal total-calorie nutrient restriction (MNR) resulted in a
13% reduction (P= 0.001) of the fetal weight at E18.5 in males
(Fig. 1a), and 14% reduction (P= 1.5 × 10–8) in birth weight of
males (Fig. 1b), relative to controls. Body weights are not sig-
nificantly different in MNR offspring between day 3 of life and
6 months (Fig. 1c), except at 1 month (P= 0.005) when controls
(23.5± 0.4) were heavier than MNR (22.3± 0.3). This protocol
demonstrated a reproducible FGR from moderate MNR.
In addition to body weight, organ weights were taken at each
dissection. Fetal liver-to-body weight ratio was 1.4-fold reduced in
MNR offspring (0.05± 0.003) relative to controls (0.07± 0.002,
P< 0.0001), indicating a disproportionate effect of maternal
nutrition on the liver (Fig. 2a). All other organs were proportion-
ally reduced with body weight. At 1 month, liver weight relative to
body weight was similar in MNR offspring (P= 0.09) (Fig. 2b), but
decreased again by 6 months (P= 0.03). These data suggest that the
disproportionate impact on the liver growth is impacted by fetal
nutrition and the effects extend into adulthood (Fig. 2c).
Whole body glucose metabolism and hepatic glucose output
was assessed with IP-GTT and pyruvate challenge tests, respec-
tively. Differences in glucose tolerance were detected with the area
under the curve (AUC) in 6-month-old MNR offspring
(1553± 57) relative to controls (1323± 68, P= 0.045) (Fig. 3a and
b). Fasting blood glucose at the time of GTT was also relatively
higher in MNR offspring (P= 0.3) (Fig. 3a); however, blood
glucose at all time points and the AUC (Supplementary Fig. 1S)
for pyruvate challenge testing indicated similar hepatic glucose
output in MNR offspring relative to controls. Therefore, moderate
differences in glucose metabolism were detected in the MNR
offspring.
Random blood glucose was measured once a month until
6 months of age. MNR offspring blood glucose level was similar to
controls each month (P-value= 0.4) (Supplementary Fig. 2S), and
the AUC did not differ (P-value= 0.3) (Supplementary Fig. 2S).
Serum peptide markers for diabetes and obesity were also
assayed at 1 and 6 months of age. At 1 month, PAI-1 was 1.9-fold
higher in MNR offspring relative to controls (P= 0.04) [Fig. 4a(i)].
PAI-1 remained 1.5-fold higher in 6-month-old MNR offspring
(P= 0.04) [Fig. 4b (i)]. Increased resistin was also detected at
this time in MNR offspring (189.8± 9.8 ng/ml) relative to
controls (171.2± 14.5 ng/ml, P= 0.04) [Fig. 4b(v)]. C-peptide,
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insulin-to-glucagon ratio, GIP, GLP, ghrelin and leptin did not
differ based on maternal nutrition at 1 and 6 months (Fig. 4).
In addition to peptide markers, lipids were measured in serum
and the right lateral liver lobe at 6 months. No differences were
observed between control and nutrient-restricted offspring in
serum triglycerides (P= 0.6) (Supplementary Fig. 3S Ai) or total
cholesterol (P= 0.7) (Supplementary Fig. 3S Aii). Moreover,
control and MNR offspring had similar liver cholesterol
(P= 0.07) (Supplementary Fig. 3S B).
Although some differences were detected in whole-body glucose
metabolism, a hepatic portal vein insulin challenge was used to
examine tissue-specific insulin sensitivity. Relative to controls, the
Fig. 2. Organ weights of male offspring at E18.5, 1 month and 6 months. (a) At E18.5, liver weight was reduced in MNR offspring relative to their body weight (P< 0.0001)
(control: n= 20, MNR: n= 15, 3 control and 3 MNR litters, 3–8 pups/litter). (b) Relative to body weight, the liver of MNR offspring was similar to controls at 1 month (P= 0.09)
(control: n= 12 from 5 litters, MNR: n= 19 from 9 litters, 1–3 pups/litter), and significantly lower at 6 months (P= 0.03) (control: n= 24, MNR: n= 30, 5 control and 10 MNR litters,
3–8 pups/litter). (c) Fetal data are mean ± SEM (a). Asterisk represents P< 0.05 evaluated by Mann–Whitney test.
Fig. 1. (a) Body weights of offspring of MNR and control from E18.5 until 6 months. At E18.5, fetal weights of MNR (n= 15) were 13% smaller than controls (n= 20) (P= 0.001)
(3 Control and 3 MNR litters, 3–8 pups/litter). (b) Birth weight of MNR offspring remained 14% smaller (P= 1.5 × 10−8) (control: n= 39 from 5 litters, MNR: n= 58 from 10 litters,
4–9 pups/litter). Except at 1 month when controls were heavier than MNR (P= 0.005), no differences were observed in weight from day 3 to 6 months. (c) From birth to 1 month
(control: n= 37, MNR: n= 52, 5 control and 10 MNR litters, 3–11 pups/litter), and from 2 to 6 months (control: n= 27, MNR: n= 36) (5 control and 10 MNR litters, 3–9 pups/litter).
Growth curve data is plotted as mean ± SEM. Asterisk represents significance (P< 0.05) evaluated by Mann–Whitney test.
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ratio of pAkt-to-Akt was 2.5-fold increased in the liver of MNR
offspring in response to the insulin injection (P= 0.004) (Fig. 5a).
Although not significant, insulin-stimulated phosphorylation of
Akt in adipose tissue (Fig. 5b) and skeletal muscle (Fig. 5c) was
relatively increased by 1.5- and 1.6-fold in the nutrient-restricted
offspring, respectively (P= 0.08 and 0.05, respectively).
Fig. 4. Serum peptide markers for obesity and diabetes at (a) 1 month (control: n= 7, MNR: n= 18; 4 control and 10 MNR litters, 1–2 pups/litter), and (b) 6 months of age
(5 control and 10 MNR litters, 3–7 pups/litter; MNR: n= 52, control: n= 30). PAI-1 was increased in MNR offspring at 1 month (P= 0.04) and 6 months (P= 0.04), (i) and resistin at
6 months (P= 0.04) (v). Ghrelin (ii), GLP-1 (iii), leptin (iv), GIP (vi), insulin-to-glucagon ratios (vii), and C-peptide (viii) levels were similar between control and MNR offspring.
Asterisk represents P< 0.05 evaluated by Mann–Whitney test.
Fig. 3. IP-GTT of male offspring at 6 months. (a) Blood glucose at 90 and 120min was significantly higher in MNR offspring (n= 36, 10 litters) relative to controls (n= 25, 5 litters,
3–8 pups/litter). The AUC was also significantly higher (P= 0.045) (b). Glucose tolerance data (a) are mean ± SEM. Asterisk represents P< 0.05 evaluated by Bonferroni post hoc
(a) or Mann–Whitney test (b).
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Although changes in glucose metabolism at the tissue-level
occurred to some extent in all MNR offspring, there was a var-
iation in the degree of response to fetal nutrient restriction on
adult glucose metabolism. At 6 months, 19% of the offspring were
less tolerant to glucose (Fig. 6a), with a higher AUC than any
controls (Fig. 6b). The remaining MNR have AUCs that were
Fig. 5. Insulin signaling as determined by phosphorylation of Akt in response to an insulin bolus in male MNR and control offspring at 7 months of age. pAkt relative to Akt after
an insulin dose was increased in MNR offspring relative to controls in the right medial liver lobe (P= 0.004) (a). pAkt-to-Akt ratios were relatively increased in MNR adipose and
(c) skeletal muscle of insulin injected mice, but this change was not significant (P= 0.08 and 0.05, respectively) (b). Saline injected n= 3 and insulin injected n= 5 for both
maternal nutrition groups, 5 control and 8 MNR litters, 1 pup/litter. Means with asterisks are significantly different (P< 0.05, unpaired t-test).
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similar to those of controls. Although differences in blood glucose
regulation were evident after the glucose bolus, random blood
glucose measurements from 1 to 6 months were not different in
less-tolerant MNR (data not shown).
Serum peptide analysis in the less-tolerant mice showed
increased insulin (P= 0.006), leptin (P= 0.001) (Fig. 7g) and
resistin (P= 0.005) (Fig. 7f) levels, with no changes in other
assayed peptide markers (Fig. 7h).
Discussion
In humans, FGR can be symmetric or asymmetric. Symmetric
FGR, meaning all organs including the brain are reduced pro-
portionately to body weight, is often associated with an insult of
early onset.25 Conversely, asymmetric FGR is more common in
late-onset growth restriction, and is where less essential organs
are reduced but vital organs such as the brain and the heart are
spared.25 Similar to humans, maternal undernutrition in mice
resulted in an asymmetric growth restriction, with the most sig-
nificant impact on the liver.26 The thymus and spleen are also
smaller relative to body weight in SGA autopsies,26 but were not
measured in this study. Although reduced again at 6 months,
1-month relative liver weights were similar to controls, which
might indicate differences in growth rate of the liver in MNR
offspring. MNR in guinea pigs do not result in reduced liver-to-
fetal weight ratios, but the fractional growth rate is increased near
term.9 These data suggest that liver growth may be more sensitive
than other organs to fetal undernutrition.
The variation in response to fetal nutrient restriction in our
model was similar to the variations observed in the human FGR
populations. Some individuals with extremely low birth weights
(ELBW) although having three times greater risk will not develop
glucose intolerance and type 2 diabetes.3 In adults, genetic var-
iation and differential expression contribute to obesity and
metabolic disorder resistant and/or susceptible populations of
nonhuman primates27 and rodent models28,29 in response to
nutritional stress, such as a high fat diet. Offspring in models
exposed to maternal high fat diet or nutrient restriction have
metabolic,7,30 gut microbe31 and epigenomic changes,32 but to our
knowledge none of these models focus on changes specific to
susceptible and resistant populations in these offspring. Having
glucose tolerant and intolerant offspring resulting from MNR
allow future studies to examine differences in glucose metabolism
within the MNR populations, as well as adaptations that occur in
all offspring exposed to nutrient restriction in utero.
In this study, normal glucose tolerance observed in 81% of the
offspring might have been due to increased insulin sensitivity as
adults, despite having smaller livers. Increased insulin sensitivity
in peripheral tissues in response to growth restriction is thought
to occur at birth and has been shown to persist a few weeks
postnatally in lambs exposed to hypoxia-induced placental
insufficiency.33 To our knowledge, evidence of insulin desensiti-
zation6,7 has been observed rather than persistence of the
increased sensitivity into adulthood. Intolerant MNR offspring,
which had higher serum insulin and relatively higher insulin-to-
glucagon ratios, might have insulin resistance that was not
detectable during insulin sensitivity test due to technical limita-
tions in sample size. Studies comparing liver responses in intol-
erant and tolerant MNR mice may provide insight into why some
offspring are able to adapt to the postnatal parameters assessed in
this study.
Despite having similar body weight at 6 months, PAI-1 and
resistin were increased in MNR offspring. Both are produced
primarily in adipose tissue in mice16,17 and are associated with
obesity and meta-inflammation.16,17,34 Individuals born SGA with
the highest body mass index (BMI) have reduced insulin sensi-
tivity,35 however, total fat pads are increased in female adult rats
that experienced 50% nutrient restriction throughout gestation
with similar adult body weights to controls.36 ELBW babies also
have similar BMI with increased body fat mass,3 suggesting that
an increased markers for obesity and meta-inflammation may
indicate reduced lean mass in response to fetal undernutrition in
male offspring, despite no differences in adult body weight. MNR
offspring with glucose intolerance had higher serum resistin,
suggesting increased fat mass may contribute to the development
of glucose intolerance.
Leptin was also increased in offspring with less glucose tol-
erance. Serum leptin is correlated with body fat mass in humans37
and mice,38 supporting the notion of differences in body com-
position. This marker could also indicate a decreased appetite in
MNR offspring, particularly in those with glucose intolerance.
Alternatively, leptin resistance occurs in diet-induced obesity, in
part, via Aβ1–42-induced basal STAT3 phosphorylation in the
hypothalamus,39 indicating that the increased leptin in offspring
with impaired glucose homeostasis may be a sign of leptin
Fig. 6. Glucose tolerance tests for all offspring of MNR and control at 6 months. (a) Individual glucose tolerance tests for controls demonstrate the range of responses. (b) 7
MNR (black) had AUC greater than other MNR or controls (grey), which are referred to as intolerant MNR (5 control and 10 MNR litters, 3–8 pups/litter).
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resistance. Leptin may also play a role in regulation of energy
expenditure39 and behavior changes, such as food preference and
total activity, which are also altered in adulthood following IUGR
or undernourishment during development.40,41 Increased serum
leptin levels suggest that behaviors and body mass composition
may be altered in all or a portion of the MNR offspring and
require further investigation.
Moderate nutrient restriction throughout gestation resulted in
changes to the liver and adipose tissue, including decreased fetal
liver weight, increased adult insulin sensitivity in the liver, and
increased serum markers for body mass composition and meta-
inflammation. Liver is well known to be important in regulation of
lipid and glucose metabolism and a key tissue in the development
of type 2 diabetes. Although it is possible that some adaptations
occur in all offspring exposed to MNR, additional physiologic and
biochemical changes in the liver and other organs may be specific
to those that develop glucose intolerance. This model provides an
opportunity to investigate the tissue-specific molecular mechanism
underlying changes between control and MNR offspring, as well as
between more affected MNR and those similar to the controls, and
Fig. 7. Serum peptide markers for obesity and diabetes in male MNR and control offspring at 6 months old according to glucose tolerance. Resistin (P= 0.005) (d) and leptin
(P= 0.001) (e) were significantly increased in MNR offspring that are glucose intolerant. PAI-1 (a), Ghrelin (b), GLP-1(c), GIP(f), insulin-to-glucagon (g) and c-peptide (h) were not
significantly different in less tolerant MNR. Control n= 30 (5 litters, 3–8 pups/litter), tolerant MNR n= 43 (10 litters, 3–8 pups/litter), intolerant MNR n= 7 (5 litters, 1–2 pups/
litter). Asterisk represents P< 0.05 by Mann–Whitney test.
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represents the diversity in human FGR populations and their
susceptibilities toward type 2 diabetes.3,4
Supplementary material. To view supplementary material for this article,
please visit https://doi.org/10.1017/S2040174418000983
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